JP2011503541A - 磁気共鳴緩和測定用の小型の磁石およびrfコイル - Google Patents
磁気共鳴緩和測定用の小型の磁石およびrfコイル Download PDFInfo
- Publication number
- JP2011503541A JP2011503541A JP2010532083A JP2010532083A JP2011503541A JP 2011503541 A JP2011503541 A JP 2011503541A JP 2010532083 A JP2010532083 A JP 2010532083A JP 2010532083 A JP2010532083 A JP 2010532083A JP 2011503541 A JP2011503541 A JP 2011503541A
- Authority
- JP
- Japan
- Prior art keywords
- probe head
- magnetic field
- region
- coil
- excitable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000005291 magnetic effect Effects 0.000 title claims abstract description 323
- 238000005259 measurement Methods 0.000 title claims abstract description 33
- 239000000523 sample Substances 0.000 claims abstract description 396
- 238000001514 detection method Methods 0.000 claims abstract description 132
- 238000000034 method Methods 0.000 claims abstract description 93
- 238000009826 distribution Methods 0.000 claims abstract description 12
- 239000003990 capacitor Substances 0.000 claims description 15
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 238000004804 winding Methods 0.000 claims 7
- 230000000875 corresponding effect Effects 0.000 description 50
- 229920000642 polymer Polymers 0.000 description 31
- 239000002105 nanoparticle Substances 0.000 description 22
- 238000005481 NMR spectroscopy Methods 0.000 description 19
- 239000011159 matrix material Substances 0.000 description 19
- 239000006249 magnetic particle Substances 0.000 description 15
- 239000000463 material Substances 0.000 description 15
- 239000000243 solution Substances 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 230000008859 change Effects 0.000 description 13
- 239000002245 particle Substances 0.000 description 13
- 230000005284 excitation Effects 0.000 description 11
- 239000012491 analyte Substances 0.000 description 10
- 239000001257 hydrogen Substances 0.000 description 10
- 229910052739 hydrogen Inorganic materials 0.000 description 10
- 239000002131 composite material Substances 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 238000009792 diffusion process Methods 0.000 description 6
- 125000000524 functional group Chemical group 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 239000000017 hydrogel Substances 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 229910000831 Steel Inorganic materials 0.000 description 5
- -1 amino CLIO Chemical compound 0.000 description 5
- 125000003277 amino group Chemical group 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 229910001172 neodymium magnet Inorganic materials 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000010959 steel Substances 0.000 description 5
- 125000003396 thiol group Chemical group [H]S* 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 229920002307 Dextran Polymers 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 4
- 230000035699 permeability Effects 0.000 description 4
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 241001091551 Clio Species 0.000 description 3
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 239000004809 Teflon Substances 0.000 description 3
- 229920006362 Teflon® Polymers 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- 238000004220 aggregation Methods 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 125000005621 boronate group Chemical class 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 108091005995 glycated hemoglobin Proteins 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- 239000002122 magnetic nanoparticle Substances 0.000 description 3
- 229920003213 poly(N-isopropyl acrylamide) Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- VHSHLMUCYSAUQU-UHFFFAOYSA-N 2-hydroxypropyl methacrylate Chemical compound CC(O)COC(=O)C(C)=C VHSHLMUCYSAUQU-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 238000000685 Carr-Purcell-Meiboom-Gill pulse sequence Methods 0.000 description 2
- 239000004971 Cross linker Substances 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 229920001397 Poly-beta-hydroxybutyrate Polymers 0.000 description 2
- 229920000331 Polyhydroxybutyrate Polymers 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M acrylate group Chemical group C(C=C)(=O)[O-] NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 2
- 150000001642 boronic acid derivatives Chemical class 0.000 description 2
- 125000005620 boronic acid group Chemical group 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- 125000003700 epoxy group Chemical group 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229920001477 hydrophilic polymer Polymers 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 125000000879 imine group Chemical group 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 125000002462 isocyano group Chemical group *[N+]#[C-] 0.000 description 2
- JMZFEHDNIAQMNB-UHFFFAOYSA-N m-aminophenylboronic acid Chemical compound NC1=CC=CC(B(O)O)=C1 JMZFEHDNIAQMNB-UHFFFAOYSA-N 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 229940031182 nanoparticles iron oxide Drugs 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 230000005298 paramagnetic effect Effects 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229920001977 poly(N,N-diethylacrylamides) Polymers 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- IZCXQDYKFFBERI-UHFFFAOYSA-N 1-(diethylamino)ethyl 2-methylprop-2-enoate Chemical compound CCN(CC)C(C)OC(=O)C(C)=C IZCXQDYKFFBERI-UHFFFAOYSA-N 0.000 description 1
- SJIXRGNQPBQWMK-UHFFFAOYSA-N 2-(diethylamino)ethyl 2-methylprop-2-enoate Chemical compound CCN(CC)CCOC(=O)C(C)=C SJIXRGNQPBQWMK-UHFFFAOYSA-N 0.000 description 1
- KUQRLZZWFINMDP-BGNLRFAXSA-N 2-[(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O KUQRLZZWFINMDP-BGNLRFAXSA-N 0.000 description 1
- WNIFCLWDGNHGMX-UHFFFAOYSA-N 3-borono-5-nitrobenzoic acid Chemical compound OB(O)C1=CC(C(O)=O)=CC([N+]([O-])=O)=C1 WNIFCLWDGNHGMX-UHFFFAOYSA-N 0.000 description 1
- SIAVMDKGVRXFAX-UHFFFAOYSA-N 4-carboxyphenylboronic acid Chemical compound OB(O)C1=CC=C(C(O)=O)C=C1 SIAVMDKGVRXFAX-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 1
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 1
- 108010062580 Concanavalin A Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229910002546 FeCo Inorganic materials 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 230000005355 Hall effect Effects 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000463 Poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol) Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 239000000370 acceptor Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000004931 aggregating effect Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000003592 biomimetic effect Effects 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- SKSRXOOFNAWNDJ-UHFFFAOYSA-N butyl 2-methylprop-2-enoate;n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C=C.CCCCOC(=O)C(C)=C SKSRXOOFNAWNDJ-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940015047 chorionic gonadotropin Drugs 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical class [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- QZSKYMMIFBLVGO-UHFFFAOYSA-N ethane-1,2-diol;2-methylprop-2-enoic acid Chemical compound OCCO.CC(=C)C(O)=O QZSKYMMIFBLVGO-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000005350 fused silica glass Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 238000001459 lithography Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000004706 metal oxides Chemical group 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000002405 nuclear magnetic resonance imaging agent Substances 0.000 description 1
- SRQMSVCCBKHGOJ-UHFFFAOYSA-N phenylboronic acid;prop-2-enamide Chemical compound NC(=O)C=C.OB(O)C1=CC=CC=C1 SRQMSVCCBKHGOJ-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000012887 quadratic function Methods 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 229920000431 shape-memory polymer Polymers 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 230000033772 system development Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000004154 testing of material Methods 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000013585 weight reducing agent Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/448—Relaxometry, i.e. quantification of relaxation times or spin density
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N24/00—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects
- G01N24/08—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects by using nuclear magnetic resonance
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/24—Arrangements or instruments for measuring magnetic variables involving magnetic resonance for measuring direction or magnitude of magnetic fields or magnetic flux
- G01R33/243—Spatial mapping of the polarizing magnetic field
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
- G01R33/30—Sample handling arrangements, e.g. sample cells, spinning mechanisms
- G01R33/302—Miniaturized sample handling arrangements for sampling small quantities, e.g. flow-through microfluidic NMR chips
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
- G01R33/30—Sample handling arrangements, e.g. sample cells, spinning mechanisms
- G01R33/307—Sample handling arrangements, e.g. sample cells, spinning mechanisms specially adapted for moving the sample relative to the MR system, e.g. spinning mechanisms, flow cells or means for positioning the sample inside a spectrometer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
- G01R33/38—Systems for generation, homogenisation or stabilisation of the main or gradient magnetic field
- G01R33/3806—Open magnet assemblies for improved access to the sample, e.g. C-type or U-type magnets
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
- G01R33/38—Systems for generation, homogenisation or stabilisation of the main or gradient magnetic field
- G01R33/383—Systems for generation, homogenisation or stabilisation of the main or gradient magnetic field using permanent magnets
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
- G01R33/32—Excitation or detection systems, e.g. using radio frequency signals
- G01R33/34—Constructional details, e.g. resonators, specially adapted to MR
- G01R33/34046—Volume type coils, e.g. bird-cage coils; Quadrature bird-cage coils; Circularly polarised coils
- G01R33/34053—Solenoid coils; Toroidal coils
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/46—NMR spectroscopy
- G01R33/465—NMR spectroscopy applied to biological material, e.g. in vitro testing
Landscapes
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- High Energy & Nuclear Physics (AREA)
- Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Dispersion Chemistry (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Investigating Or Analyzing Materials By The Use Of Magnetic Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202207P | 2007-11-06 | 2007-11-06 | |
| US899107P | 2007-12-21 | 2007-12-21 | |
| PCT/US2008/012592 WO2009061481A1 (en) | 2007-11-06 | 2008-11-06 | Small magnet and rf coil for magnetic resonance relaxometry |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011503541A true JP2011503541A (ja) | 2011-01-27 |
| JP2011503541A5 JP2011503541A5 (https=) | 2011-12-22 |
Family
ID=40626087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010532083A Pending JP2011503541A (ja) | 2007-11-06 | 2008-11-06 | 磁気共鳴緩和測定用の小型の磁石およびrfコイル |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US8519708B2 (https=) |
| EP (1) | EP2217951A4 (https=) |
| JP (1) | JP2011503541A (https=) |
| AU (1) | AU2008325088A1 (https=) |
| CA (1) | CA2704674A1 (https=) |
| WO (1) | WO2009061481A1 (https=) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10296889B2 (en) | 2008-09-30 | 2019-05-21 | Apple Inc. | Group peer-to-peer financial transactions |
| US10380573B2 (en) | 2008-09-30 | 2019-08-13 | Apple Inc. | Peer-to-peer financial transaction devices and methods |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009045354A1 (en) | 2007-09-28 | 2009-04-09 | T2 Biosystems, Inc. | Nmr diagnostics by means of a plastic sample container |
| WO2010051362A1 (en) | 2008-10-29 | 2010-05-06 | T2 Biosystems, Inc. | Nmr detection of coagulation time |
| WO2012054639A2 (en) | 2010-10-22 | 2012-04-26 | T2 Biosystems, Inc. | Nmr systems and methods for the rapid detection of analytes |
| US8409807B2 (en) | 2010-10-22 | 2013-04-02 | T2 Biosystems, Inc. | NMR systems and methods for the rapid detection of analytes |
| US8563298B2 (en) | 2010-10-22 | 2013-10-22 | T2 Biosystems, Inc. | NMR systems and methods for the rapid detection of analytes |
| US9182465B2 (en) | 2011-03-04 | 2015-11-10 | Siemens Aktiengesellschaft | MRT gradient system with integrated main magnetic field generation |
| EP3321373B1 (en) | 2011-07-13 | 2020-01-15 | T2 Biosystems, Inc. | Nmr methods for monitoring blood clot formation |
| EP2748651B1 (en) | 2011-09-21 | 2017-08-30 | T2 Biosystems, Inc. | Nmr methods for endotoxin analysis |
| US9562271B2 (en) | 2012-04-20 | 2017-02-07 | T2 Biosystems, Inc. | Compositions and methods for detection of Candida species |
| US9739733B2 (en) | 2012-12-07 | 2017-08-22 | T2 Biosystems, Inc. | Methods for monitoring tight clot formation |
| EP2932289A1 (en) * | 2012-12-17 | 2015-10-21 | General Electric Company | In-vitro magnetic resonance detection of a target substance |
| MX361132B (es) * | 2013-03-01 | 2018-11-28 | Halliburton Energy Services Inc | Diferenciacion en el fondo del pozo de filtrados a base de aceite y petroleo ligero mediante rmn con nanoparticulas oleofilicas. |
| US9658176B2 (en) * | 2013-03-15 | 2017-05-23 | Monsanto Technology Llc | High-throughput sorting of small objects via oil and/or moisture content using low-field nuclear magnetic resonance |
| DK3038527T3 (da) * | 2013-09-05 | 2023-12-11 | Massachusetts Inst Technology | Hurtig, ikke-invasiv bestemmelse af hydreringstilstand eller vaskulært volumen af et individ |
| US9300774B2 (en) * | 2014-01-03 | 2016-03-29 | Choon-Teak Oh | Mobile terminal and its case with hall IC driving shield magnet |
| US11300531B2 (en) | 2014-06-25 | 2022-04-12 | Aspect Ai Ltd. | Accurate water cut measurement |
| US10094897B2 (en) | 2014-07-25 | 2018-10-09 | Gersh Z. Taicher | Nuclear magnetic resonance apparatus and methods |
| US10197564B2 (en) | 2014-07-25 | 2019-02-05 | Gersh Z. Taicher | Nuclear magnetic resonance apparatus and methods |
| US9817093B2 (en) | 2014-09-05 | 2017-11-14 | Hyperfine Research, Inc. | Low field magnetic resonance imaging methods and apparatus |
| US10349870B1 (en) | 2014-09-22 | 2019-07-16 | Verily Life Sciences Llc | Magnetic switching |
| US9999380B1 (en) | 2014-09-22 | 2018-06-19 | Verily Life Sciences Llc | Segmented magnets |
| US9817094B2 (en) | 2014-11-05 | 2017-11-14 | Gersh Z. Taicher | Nuclear magnetic resonance apparatus and methods |
| US9964501B2 (en) | 2014-11-05 | 2018-05-08 | Gersh Z. Taicher | Nuclear magnetic resonance apparatus and methods |
| US10082594B2 (en) | 2015-04-07 | 2018-09-25 | Baker Hughes, A Ge Company, Llc | Magnet arrays for magnetic resonance measurements |
| US10228336B2 (en) * | 2015-09-01 | 2019-03-12 | Chevron U.S.A. Inc. | Mobile NMR sensor for analyzing subsurface samples |
| US10492709B2 (en) | 2015-11-19 | 2019-12-03 | Verily Life Sciences Llc | Magnetic probes for in vivo capture and detection of extracellular vesicles |
| WO2017127731A1 (en) | 2016-01-21 | 2017-07-27 | T2 Biosystems, Inc. | Nmr methods and systems for the rapid detection of bacteria |
| US10627464B2 (en) | 2016-11-22 | 2020-04-21 | Hyperfine Research, Inc. | Low-field magnetic resonance imaging methods and apparatus |
| US10539637B2 (en) | 2016-11-22 | 2020-01-21 | Hyperfine Research, Inc. | Portable magnetic resonance imaging methods and apparatus |
| JP2019535424A (ja) | 2016-11-22 | 2019-12-12 | ハイパーファイン リサーチ,インコーポレイテッド | 磁気共鳴画像における自動検出のためのシステムおよび方法 |
| US20180184973A1 (en) * | 2016-12-29 | 2018-07-05 | Krishna Nayak | Magnetic measurement of fat fraction |
| US10345251B2 (en) * | 2017-02-23 | 2019-07-09 | Aspect Imaging Ltd. | Portable NMR device for detecting an oil concentration in water |
| US20210141036A1 (en) * | 2017-07-06 | 2021-05-13 | Terence Cosgrove | Portable nmr probe and nmr apparatus |
| US20190022665A1 (en) * | 2017-07-24 | 2019-01-24 | Dexter Magnetic Technologies, Inc. | Device for Magnetic Bead Resuspension |
| US10775458B2 (en) * | 2018-03-05 | 2020-09-15 | Texas Tech University System | Method and system for non-invasive measurement of metabolic health |
| DE102020202830A1 (de) * | 2020-03-05 | 2021-09-09 | Siemens Healthcare Gmbh | Magnetresonanztomograph und Verfahren zum Betrieb mit dynamischer B0-Kompensation |
| US12188900B2 (en) * | 2021-02-11 | 2025-01-07 | Government Of The United States Of America, As Represented By The Secretary Of Commerce | System and method for measurment of magnetic nanoparticles |
| US20250244224A1 (en) * | 2024-01-26 | 2025-07-31 | Saudi Arabian Oil Company | Digital portable magentic particle tester |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0950913A (ja) * | 1995-08-07 | 1997-02-18 | Sumitomo Special Metals Co Ltd | 磁性流体制御用磁界発生装置 |
| JP2002325743A (ja) * | 2001-05-02 | 2002-11-12 | Shin Etsu Chem Co Ltd | Mri用磁気回路構造 |
| JP2004305744A (ja) * | 2003-04-04 | 2004-11-04 | Ge Medical Systems Global Technology Co Llc | Mri用磁場生成器の中心磁場を調節するための方法及び装置 |
| JP2006030743A (ja) * | 2004-07-20 | 2006-02-02 | Konica Minolta Business Technologies Inc | 画像形成装置 |
| WO2007020537A2 (en) * | 2005-07-05 | 2007-02-22 | Commissariat A L'energie Atomique | Apparatus for high resolution nmr spectroscopy and/or imaging with an improved filling factor and rf field amplitude |
| JP2007097761A (ja) * | 2005-10-03 | 2007-04-19 | Neomax Co Ltd | 磁界発生装置 |
| US20070116602A1 (en) * | 2005-08-31 | 2007-05-24 | Bioplex Systems Inc. | NMR device for detection of analytes |
Family Cites Families (85)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5913521B2 (ja) | 1975-06-19 | 1984-03-30 | メイトウサンギヨウ カブシキガイシヤ | 磁性酸化鉄・デキストラン複合体の製造法 |
| US4452773A (en) | 1982-04-05 | 1984-06-05 | Canadian Patents And Development Limited | Magnetic iron-dextran microspheres |
| US4574240A (en) * | 1983-07-19 | 1986-03-04 | The Regents Of The University Of California | Method for flow measurement using nuclear magnetic resonance |
| US4920061A (en) | 1984-03-02 | 1990-04-24 | The University Of Texas System | Biological magnetic colloids |
| US4638253A (en) * | 1984-10-29 | 1987-01-20 | General Electric Company | Mutual inductance NMR RF coil matching device |
| US5262176A (en) | 1986-07-03 | 1993-11-16 | Advanced Magnetics, Inc. | Synthesis of polysaccharide covered superparamagnetic oxide colloids |
| US5055787A (en) * | 1986-08-27 | 1991-10-08 | Schlumberger Technology Corporation | Borehole measurement of NMR characteristics of earth formations |
| US4875486A (en) | 1986-09-04 | 1989-10-24 | Advanced Techtronics, Inc. | Instrument and method for non-invasive in vivo testing for body fluid constituents |
| US5136095A (en) | 1987-05-19 | 1992-08-04 | Syntex (U.S.A.) Inc. | Reversible agglutination mediators |
| EP0446260B1 (en) | 1988-11-21 | 1994-03-02 | Dynal A.S. | Nucleic acid probes |
| US5049819A (en) | 1989-06-30 | 1991-09-17 | Auburn International, Inc. | Magnetic resonance analysis in real time, industrial usage mode |
| JP2726520B2 (ja) | 1989-10-20 | 1998-03-11 | 名糖産業株式会社 | 有機磁性複合体 |
| US5164297A (en) | 1990-05-03 | 1992-11-17 | Advanced Magnetics Inc. | Solvent mediated relaxation assay system |
| US5254460A (en) | 1990-05-03 | 1993-10-19 | Advanced Magnetics, Inc. | Solvent mediated relaxation assay system |
| IL98744A0 (en) | 1990-07-06 | 1992-07-15 | Gen Hospital Corp | Method of studying biological tissue using monocrystalline particles |
| EP0543020B1 (en) | 1991-06-11 | 1997-12-29 | Meito Sangyo Kabushiki Kaisha | Oxidized composite comprising water-soluble carboxypolysaccharide and magnetic iron oxide |
| US5445970A (en) | 1992-03-20 | 1995-08-29 | Abbott Laboratories | Magnetically assisted binding assays using magnetically labeled binding members |
| US5445971A (en) | 1992-03-20 | 1995-08-29 | Abbott Laboratories | Magnetically assisted binding assays using magnetically labeled binding members |
| US5637469A (en) | 1992-05-01 | 1997-06-10 | Trustees Of The University Of Pennsylvania | Methods and apparatus for the detection of an analyte utilizing mesoscale flow systems |
| JP3362192B2 (ja) | 1994-12-06 | 2003-01-07 | 味の素株式会社 | 検査方法及び検査薬 |
| US6097188A (en) | 1995-01-31 | 2000-08-01 | The Board Of Trustees Of The University Of Illinois | Microcoil based micro-NMR spectrometer and method |
| US6884357B2 (en) | 1995-02-21 | 2005-04-26 | Iqbal Waheed Siddiqi | Apparatus and method for processing magnetic particles |
| US6500343B2 (en) | 1995-02-21 | 2002-12-31 | Iqbal W. Siddiqi | Method for mixing and separation employing magnetic particles |
| US5592083A (en) * | 1995-03-08 | 1997-01-07 | Quantum Magnetics, Inc. | System and method for contraband detection using nuclear quadrupole resonance including a sheet coil and RF shielding via waveguide below cutoff |
| US5572132A (en) | 1995-08-15 | 1996-11-05 | Pulyer; Yuly M. | MRI probe for external imaging |
| US6297062B1 (en) | 1996-03-07 | 2001-10-02 | Bio-Magnetics Ltd. | Separation by magnetic particles |
| EP0920627B1 (en) | 1996-06-07 | 2004-05-12 | Immunivest Corporation | Magnetic separation employing external and internal gradients |
| US6361944B1 (en) | 1996-07-29 | 2002-03-26 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
| ES2287956T3 (es) | 1996-07-29 | 2007-12-16 | Nanosphere Inc. | Nanoparticulas que tienen oligonucleotidos unidos a las mismas y usos de las mismas. |
| WO1998008899A1 (en) | 1996-08-30 | 1998-03-05 | Meito Sangyo Kabushiki Kaisha | Polysaccharide derivative/magnetic metal oxide composite |
| US5910728A (en) | 1996-11-12 | 1999-06-08 | Beth Israel Deaconess Medical Center | Simultaneous acquisition of spatial harmonics (SMASH): ultra-fast imaging with radiofrequency coil arrays |
| FR2758884B1 (fr) | 1997-01-30 | 1999-04-02 | Bio Merieux | Procede pour isoler, notamment detecter ou quantifier un analyte dans un milieu |
| DE19822123C2 (de) | 1997-11-21 | 2003-02-06 | Meinhard Knoll | Verfahren und Vorrichtung zum Nachweis von Analyten |
| US6194900B1 (en) | 1998-06-19 | 2001-02-27 | Agilent Technologies, Inc. | Integrated miniaturized device for processing and NMR detection of liquid phase samples |
| WO2000050924A1 (en) * | 1999-02-26 | 2000-08-31 | Purdue Research Foundation | Nuclear magnetic resonance analysis of multiple samples |
| DK1169062T3 (da) | 1999-04-09 | 2010-01-25 | Amag Pharmaceuticals Inc | Varmestabile overtrukne kolloide jernoxider |
| DE60045739D1 (de) | 1999-06-25 | 2011-04-28 | Nanosphere Inc | Nanopartikel mit gebundenen oligonukleotiden und deren verwendungen |
| AU6828500A (en) | 1999-08-06 | 2001-03-05 | Institut Fur Diagnostikforschung Gmbh An Der Freien Universitat Berlin | Method for detecting binding reactions through measurement of the relaxation of birefringence of magnetic nanoparticles |
| US6767635B1 (en) | 1999-09-14 | 2004-07-27 | Biomedical Apherese Systeme Gmbh | Magnetic nanoparticles having biochemical activity, method for the production thereof and their use |
| US6294342B1 (en) | 1999-09-29 | 2001-09-25 | Abbott Laboratories | Magnetically assisted binding assays utilizing a magnetically responsive reagent |
| US6254830B1 (en) | 1999-11-05 | 2001-07-03 | The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations | Magnetic focusing immunosensor for the detection of pathogens |
| FR2800635B1 (fr) | 1999-11-05 | 2002-07-26 | Bio Merieux | Nanospheres composites, conjugues derives, procede de preparation et leurs utilisations |
| CN1217201C (zh) * | 2000-01-19 | 2005-08-31 | 千年技术公司 | C形磁共振成象系统 |
| US6548264B1 (en) | 2000-05-17 | 2003-04-15 | University Of Florida | Coated nanoparticles |
| US6456072B1 (en) | 2000-05-26 | 2002-09-24 | The Board Of Trustees Of The University Of Illinois | Method and apparatus for simultaneous acquisition of high resolution NMR spectra from multiple samples |
| US6788061B1 (en) | 2000-08-01 | 2004-09-07 | The Board Of Trustees Of The University Of Illinois | Microcoil based micro-NMR spectrometer and method |
| US6489767B1 (en) * | 2000-09-06 | 2002-12-03 | Quantum Magnetics, Inc. | Apparatus for and method of single-sided magnetic resonance imaging with palm-size probe |
| WO2002056049A2 (en) | 2000-12-01 | 2002-07-18 | Protasis Corp | Microfluidic device with multiple microcoil nmr detectors |
| US6940378B2 (en) | 2001-01-19 | 2005-09-06 | Halliburton Energy Services | Apparatus and method for magnetic resonance measurements in an interior volume |
| DE10113661A1 (de) | 2001-03-21 | 2002-09-26 | Philips Corp Intellectual Pty | Katheter zur Anwendung in einem Magnetresonanz-Bildgerät |
| US7200430B2 (en) | 2001-03-29 | 2007-04-03 | The Regents Of The University Of California | Localized two-dimensional shift correlated MR spectroscopy of human brain |
| FR2824563B1 (fr) | 2001-05-10 | 2004-12-03 | Bio Merieux | Particules composites, conjugues derives, procede de preparation et applications |
| US20030092029A1 (en) | 2001-06-06 | 2003-05-15 | Lee Josephson | Magneitc-nanoparticle conjugates and methods of use |
| US6809519B2 (en) | 2001-07-12 | 2004-10-26 | Shin-Etsu Chemical Co., Ltd. | Inclined magnetic field generation coil and magnetic field generator for MRI |
| FR2832507B1 (fr) | 2001-11-20 | 2004-02-20 | Stago Diagnostica | Methode de detection d'analyte(s) a l'aide de particules magnetiques colloidales |
| US7018849B2 (en) | 2002-01-15 | 2006-03-28 | Piasio Roger N | Process for (A) separating biological/ligands from dilute solutions and (B) conducting an immunochromatographic assay thereof employing superparamagnetic particles throughtout |
| CA2418229A1 (en) | 2002-05-16 | 2003-11-16 | Rohan Dharmakumar | Microbubble construct for sensitivity enhanced mr manometry |
| US6798200B2 (en) | 2002-06-03 | 2004-09-28 | Long-Sheng Fan | Batch-fabricated gradient and RF coils for submicrometer resolution magnetic resonance imaging and manipulation |
| US20040018611A1 (en) | 2002-07-23 | 2004-01-29 | Ward Michael Dennis | Microfluidic devices for high gradient magnetic separation |
| AU2003303954A1 (en) | 2002-10-25 | 2004-10-11 | Emory University | Multifunctional magnetic nanoparticle probes for intracellular molecular imaging and monitoring |
| US7217542B2 (en) | 2002-10-31 | 2007-05-15 | Hewlett-Packard Development Company, L.P. | Microfluidic system for analyzing nucleic acids |
| US20080305048A1 (en) | 2003-12-10 | 2008-12-11 | The General Hospital Corporation | Self-Assembling Nanoparticle Conjugates |
| WO2005099419A2 (en) | 2004-04-13 | 2005-10-27 | President And Fellows Of Harvard College | Manipulation and/or detection of biological samples or other objects |
| EP1751534A1 (en) | 2004-05-18 | 2007-02-14 | Koninklijke Philips Electronics N.V. | Magnetic rotation to improve signal-over-background in biosensing |
| JP4849623B2 (ja) | 2004-09-13 | 2012-01-11 | 学校法人慶應義塾 | 試料中のプロトン性溶媒量を局所的に測定する方法、装置 |
| US7781228B2 (en) | 2005-04-07 | 2010-08-24 | Menon & Associates, Inc. | Magnetic resonance system and method to detect and confirm analytes |
| CA2606924C (en) | 2005-05-09 | 2013-04-16 | The General Hospital Corporation | Water relaxation-based sensors |
| FR2894970B1 (fr) | 2005-12-15 | 2008-01-25 | Biomerieux Sa | Procede de preparation de particules composites, particules composites obtenues et leur utilisation dans un test diagnostic |
| US7345479B2 (en) * | 2005-12-29 | 2008-03-18 | Intel Corporation | Portable NMR device and method for making and using the same |
| US20070166730A1 (en) | 2006-01-19 | 2007-07-19 | Menon & Associates, Inc. | Magnetic resonance system and method to detect and confirm analytes |
| US7525310B2 (en) | 2006-03-04 | 2009-04-28 | Raju Viswanathan | Signal acquisition and processing method and apparatus for magnetic resonance imaging |
| WO2007106765A2 (en) * | 2006-03-11 | 2007-09-20 | Xigo Nanotools Llc | Compact and portable low-field pulsed nmr dispersion analyzer |
| JP5385131B2 (ja) | 2006-06-21 | 2014-01-08 | スピノミックス エス.エイ. | 液体媒体中で磁性粒子を操作及び混合するためのデバイス及び方法 |
| US8339135B2 (en) | 2006-08-21 | 2012-12-25 | Stc.Unm | Biological detector and method |
| TWI322793B (en) | 2006-10-02 | 2010-04-01 | Chung Cheng Inst Of Technology Nat Defense University | Functionalized magnetizable microspheres and preparation thereof |
| US8368402B2 (en) | 2006-11-08 | 2013-02-05 | T2 Biosystems, Inc. | NMR systems for in vivo detection of analytes |
| EP2092339B1 (en) | 2006-12-12 | 2012-05-16 | Koninklijke Philips Electronics N.V. | Microelectronic sensor device for detecting label particles |
| JP2010522888A (ja) | 2007-03-27 | 2010-07-08 | アブクマー インコーポレイテッド | ラベリングされたエンティティをマイクロコイル磁気mriを用いて検出するシステムおよび方法 |
| US8067938B2 (en) | 2007-05-03 | 2011-11-29 | Abqmr, Inc. | Microcoil NMR detectors |
| EP2186034A2 (en) | 2007-07-26 | 2010-05-19 | T2 Biosystems, Inc. | Diagnostic information generation and use |
| US20110070657A1 (en) | 2007-08-17 | 2011-03-24 | The General Hospital Corporation | Detecting ions and measuring ion concentrations |
| WO2009045354A1 (en) | 2007-09-28 | 2009-04-09 | T2 Biosystems, Inc. | Nmr diagnostics by means of a plastic sample container |
| AU2008343871B2 (en) | 2007-12-21 | 2014-02-06 | T2 Biosystems, Inc. | Magnetic resonance system with implantable components and methods of use thereof |
| US20110275985A1 (en) | 2008-07-03 | 2011-11-10 | T2 Biosystems, Inc. | Magnetic nanosensor compositions and bioanalytical assays therefor |
| WO2010051362A1 (en) | 2008-10-29 | 2010-05-06 | T2 Biosystems, Inc. | Nmr detection of coagulation time |
-
2008
- 2008-11-06 AU AU2008325088A patent/AU2008325088A1/en not_active Abandoned
- 2008-11-06 WO PCT/US2008/012592 patent/WO2009061481A1/en not_active Ceased
- 2008-11-06 CA CA2704674A patent/CA2704674A1/en not_active Abandoned
- 2008-11-06 JP JP2010532083A patent/JP2011503541A/ja active Pending
- 2008-11-06 US US12/741,789 patent/US8519708B2/en not_active Expired - Fee Related
- 2008-11-06 EP EP08848455A patent/EP2217951A4/en not_active Withdrawn
-
2013
- 2013-08-23 US US13/974,477 patent/US9632154B2/en not_active Expired - Fee Related
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0950913A (ja) * | 1995-08-07 | 1997-02-18 | Sumitomo Special Metals Co Ltd | 磁性流体制御用磁界発生装置 |
| JP2002325743A (ja) * | 2001-05-02 | 2002-11-12 | Shin Etsu Chem Co Ltd | Mri用磁気回路構造 |
| JP2004305744A (ja) * | 2003-04-04 | 2004-11-04 | Ge Medical Systems Global Technology Co Llc | Mri用磁場生成器の中心磁場を調節するための方法及び装置 |
| JP2006030743A (ja) * | 2004-07-20 | 2006-02-02 | Konica Minolta Business Technologies Inc | 画像形成装置 |
| WO2007020537A2 (en) * | 2005-07-05 | 2007-02-22 | Commissariat A L'energie Atomique | Apparatus for high resolution nmr spectroscopy and/or imaging with an improved filling factor and rf field amplitude |
| US20070116602A1 (en) * | 2005-08-31 | 2007-05-24 | Bioplex Systems Inc. | NMR device for detection of analytes |
| JP2007097761A (ja) * | 2005-10-03 | 2007-04-19 | Neomax Co Ltd | 磁界発生装置 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10296889B2 (en) | 2008-09-30 | 2019-05-21 | Apple Inc. | Group peer-to-peer financial transactions |
| US10380573B2 (en) | 2008-09-30 | 2019-08-13 | Apple Inc. | Peer-to-peer financial transaction devices and methods |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2704674A1 (en) | 2009-05-14 |
| WO2009061481A1 (en) | 2009-05-14 |
| US9632154B2 (en) | 2017-04-25 |
| EP2217951A4 (en) | 2011-05-18 |
| US20130342205A1 (en) | 2013-12-26 |
| EP2217951A1 (en) | 2010-08-18 |
| US8519708B2 (en) | 2013-08-27 |
| AU2008325088A1 (en) | 2009-05-14 |
| US20100308822A1 (en) | 2010-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9632154B2 (en) | Small magnet and RF coil for magnetic resonance relaxometry | |
| US10184907B2 (en) | Magnetic nanosensor compositions and bioanalytical assays therefor | |
| EP2385386B1 (en) | Magnetic resonance sensors for monitoring of an analyte concentration | |
| AU2008343871B2 (en) | Magnetic resonance system with implantable components and methods of use thereof | |
| Issadore et al. | Miniature magnetic resonance system for point-of-care diagnostics | |
| Haun et al. | Magnetic nanoparticle biosensors | |
| US10663548B2 (en) | System and method for magnetic resonance imaging | |
| US20060210987A1 (en) | Method for the spatially resolved determination of physcial, chemical and/or biological properties or state variables | |
| Loewa et al. | Cellular uptake of magnetic nanoparticles quantified by magnetic particle spectroscopy | |
| Demas et al. | Magnetic resonance for in vitro medical diagnostics: superparamagnetic nanoparticle-based magnetic relaxation switches | |
| Lowery | Nanomaterials-based magnetic relaxation switch biosensors | |
| Sukerkar et al. | Polystyrene microsphere–ferritin conjugates: A robust phantom for correlation of relaxivity and size distribution | |
| US12607692B2 (en) | Implantable biosensor containing a magnetic nanoparticle assay for in vivo analyte detection | |
| WO2013049457A1 (en) | Micro-magnetic resonance system and method for managing anlaysis data |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111104 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20111104 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20121205 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130924 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20131220 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140106 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140324 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20141007 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20150324 |